Previous close | 13.02 |
Open | 13.02 |
Bid | 13.90 |
Ask | 14.40 |
Strike | 100.00 |
Expiry date | 2025-01-17 |
Day's range | 13.02 - 13.02 |
Contract range | N/A |
Volume | |
Open interest | 10 |
Stryker's (SYK) first-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
DexCom's (DXCM) first-quarter 2024 results are likely to reflect rising volumes across all channels.
West Pharmaceutical's (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.